Christine Schmotzer, MD, FCAP, comments on the newly released FDA drafted guidelines. “This recommendation is coming after years of thoughtful data-driven research focused on safety at the blood supply in risk of the patient,” said Dr. Schmotzer, who is the Vice Chair of System Pathology Operations. “We are in a situation where we do have a critical need for blood products."
For the full article click here: A potential move by the FDA could break barriers for gay, bisexual men